Webinar about the Brand New Features of Omixon Target HLA Typing 1.6

02/09/2013

Broadcasting time: 20th Sep, 6 – 7 PM CEST Come and join us online in a presentation about HLA typing by NGS and analysing result with Omixon Target. Our presenter will be Tim Hague, recently appointed CEO of Omixon. REGISTER HERE This webinar will be about the new HLA Typing...

Omixon at BSHI 2013 in Manchester

02/09/2013

We are going to exhibit at the upcoming BSHI 2013 meeting, 4-5 September 2013, Manchester, UK. Manchester has historically been a scientific centre in the UK; home to scientists such as Dalton, Rutherford and more recently Alan Turing and Professor Brian Cox. We are happy to announce that our recently appointed CEO, Tim Hague...

Congratulations to Omixon’s new CEO!

13/08/2013

We congratulate Tim Hague for taking over the CEO responsibilities for Omixon. Attila Berces will continue as Chairman of the Board and will focus on the strategic relationships of the company. “Tim has demonstrated outstanding leadership qualities and it is a natural step for him to advance to the top,”...

US Supreme Court Rules on DNA Patents

14/06/2013

A long debate comes to an end today as the US Supreme Court upends patentability of genes! The supreme court decision opens opportunities for BRCA testing by Next Generation Sequencing, but how you find those long indels? This is where we help! Here is how our method was checked and...

Omixon and Knome partner to offer advanced HLA typing for whole genome!

05/06/2013

We have great news today as Omixon Biocomputing and Knome has become partners to offer advanced HLA typing for whole genome and exome level data. We believe that this partnership will help us “discover safer and more efficient therapies by identifying genomic biomarkers for drug response and adverse response,” as...